Search for Clinical Trials

Search by Keyword

Search by Topic Allergy/Immunology/RheumatologyAlzheimer's DiseaseAnxietyAsthma/COPDAutismBones/Joints/MusclesBrain/Spinal Cord/Nervous SystemCancer - AllCancer - Bile Duct/Gallbladder CancerCancer - BladderCancer - BrainCancer - BreastCancer - CervicalCancer - Colon/RectalCancer - EndometrialCancer - EsophagusCancer - Gastric/StomachCancer - Head/NeckCancer - HematologyCancer - Kidney/RenalCancer - LeukemiaCancer - LiverCancer - LungCancer - LymphomaCancer - MetastaticCancer - MyelomaCancer - NeuroblastomaCancer - Non-Hodgkin LymphomaCancer - PancreasCancer - ProstateCancer - SarcomaCancer - Stem Cell TransplantCoronavirusCovid-19Depression and Mood DisordersDiabetesDigestive SystemEar/Nose/ThroatEmergency MedicineEndocrinologyEpilepsyEye and VisionFetal Surgery and InterventionGenetic and Rare Diseases - Observational and Gene DiscoveryGenetic and Rare Diseases - TreatmentGeriatricsGrowth and DevelopmentHead and NeckHealthy Volunteers - AdultHealthy Volunteers - ChildHeartHematologyInfectious Diseases/Immune SystemKidneyLipids and CholesterolLiverLungMaternal-Fetal MedicineMen's HealthMesotheliomaNeurovascularNutritionObesity and MetabolismObsessive Compulsive Disorder OCDObstetrics and GynecologyPediatricsPeripheral Artery DiseasePsychiatry and BehaviorSpineSubstance AbuseTriglycerideTriglyceridesUrologyVaccineVascularVeteran HealthWearable TechnologyWomen's Health

Apply Filter

Phase I study for the treatment of patients with GD2-expressing brain tumors (GAIL B) (H-45668)

Phase I study of autologous T lymphocytes expressing GD2-specific chimeric antigen and constitutively active IL-7 receptors for the treatment of…

• Cancer - Brain
• Cancer - All
• Brain/Spinal Cord/Nervous System

View Clinical Trial